A5001785295- Gastric Cancer Management and Outcomes
- Psychedelics and Drug Studies
- Cancer, Lipids, and Metabolism
- Chemical synthesis and alkaloids
- Frailty in Older Adults
- RNA modifications and cancer
- Nanoplatforms for cancer theranostics
- Antiplatelet Therapy and Cardiovascular Diseases
- Ultrasound and Hyperthermia Applications
- Intestinal and Peritoneal Adhesions
- Inflammatory mediators and NSAID effects
- Esophageal Cancer Research and Treatment
- Health Systems, Economic Evaluations, Quality of Life
- Intraperitoneal and Appendiceal Malignancies
- Neurotransmitter Receptor Influence on Behavior
University of North Texas
2021-2025
University of North Texas Health Science Center
2021-2025
University of Dundee
2024
NHS Tayside
2021-2024
Ninewells Hospital
2021
Christus Stehlin Foundation for Cancer Research
1990
St. Joseph Hospital
1990
Abstract Psychedelics are well known for their ability to produce profoundly altered states of consciousness. But, more importantly, the effects psychedelics can influence neurobehavioral changes that last after these acute subjective end. This phenomenon is currently being leveraged in development psychedelic-assisted psychotherapies treatment multiple neuropsychiatric disorders. The cellular and molecular mechanisms by which single doses able mediate long-term cognitive an active area...
Reconstituted high-density lipoprotein nanoparticles (NPs), which mimic the structure and function of endogenous human plasma HDL, hold promise as a robust drug delivery system. These nanoparticles, when loaded with appropriate agents, serve powerful tools for targeted delivery. The fundamental challenge lies in controlling estimating actual load efficiency release at target. In this report, we present novel approach based on enhanced Förster Resonance Energy Transfer (FRET) to assess...
Abstract Based on data from the World Health Organization, breast cancer is most common type of among women, accounting for about 15% all cancer-related deaths. Thus, new treatment options are urgently needed to decrease this mortality rate. In recent years, mesoionic compounds have shown promising potential as anti-cancer agents due their unique structure and reaction properties. We recently reported that a 1,3-thiazolium-5-thiolate compound (MIH 2.4Bl) inhibited oxidative phosphorylation...